SCHEMBL4847516

SCHEMBL4847516

COc1ccc(C(=O)C=Cc2cc(-c3ccccc3)ccc2OCCN(C)C)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.50
PDE4A P27815 1/20 0.47
PDE4B Q07343 1/20 0.47
PDE4C Q08493 1/20 0.47
PDE4D Q08499 1/20 0.47
TNFRSF1A P19438 1/20 0.45
MCHR1 Q99705 1/20 0.45
APP P05067 1/20 0.44
SLC6A9 P48067 2/20 0.44
BCHE P06276 2/20 0.44
ACHE P22303 2/20 0.44
MAPT P10636 2/20 0.43
MEN1 O00255 1/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
ESR1 P03372 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4854790 0.90 ABCG2 (0.50) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4852991 0.90 ABCG2 (0.49) ABCG2MCHR1SLC6A9BCHEACHE
SCHEMBL4847513 0.90 ABCG2 (0.49) ABCG2MCHR1SLC6A9BCHEACHE
SCHEMBL14280885 0.90 PDE4A (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4848333 0.90 PDE4A (0.46) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4848038 0.89 ABCG2 (0.47) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4854497 0.89 MEN1 (0.48) ABCG2PDE4APDE4BPDE4CPDE4D
SCHEMBL4849165 0.85 BCHE (0.58) ABCG2TNFRSF1AMCHR1BCHEACHE
SCHEMBL4845551 0.84 MCHR1 (0.49) TNFRSF1AMCHR1SLC6A9BCHEACHE
SCHEMBL4848052 0.83 ABCG2 (0.48) ABCG2PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed